Trending/Edith Perez
Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER-2+ Breast Cancer Patients, Study Finds
JACKSONVILLE, Fla. — A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also…
Special Topics
Sign up

Social Media Network
A network for digital healthcare communicators

Mayo Clinic Connect
An online patient support community